These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 16644496)

  • 1. Induction of immunological tolerance using monoclonal antibodies: applications to organ transplantation and autoimmune disease.
    Bach JF
    C R Biol; 2006 Apr; 329(4):260-2. PubMed ID: 16644496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell immunomodulation--the Holy Grail of therapeutic tolerance.
    Isaacs JD
    Curr Opin Pharmacol; 2007 Aug; 7(4):418-25. PubMed ID: 17611158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD3-specific antibodies restore self-tolerance: mechanisms and clinical applications.
    Chatenoud L
    Curr Opin Immunol; 2005 Dec; 17(6):632-7. PubMed ID: 16214320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD3-specific antibody-induced active tolerance: from bench to bedside.
    Chatenoud L
    Nat Rev Immunol; 2003 Feb; 3(2):123-32. PubMed ID: 12563296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T cells in the induction and maintenance of peripheral transplantation tolerance.
    Cobbold SP; Graca L; Lin CY; Adams E; Waldmann H
    Transpl Int; 2003 Feb; 16(2):66-75. PubMed ID: 12595967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of monoclonal antibodies to achieve immunological tolerance.
    Waldmann H; Cobbold S
    Immunol Today; 1993 Jun; 14(6):247-51. PubMed ID: 8397765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of CD3-specific antibodies in autoimmune diabetes: a step toward the induction of immune tolerance in the clinic.
    Chatenoud L
    Handb Exp Pharmacol; 2008; (181):221-36. PubMed ID: 18071948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD3 antibodies.
    Chatenoud L; Bach JF
    Immunol Ser; 1993; 59():175-91. PubMed ID: 8461387
    [No Abstract]   [Full Text] [Related]  

  • 9. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells.
    Ochi H; Abraham M; Ishikawa H; Frenkel D; Yang K; Basso AS; Wu H; Chen ML; Gandhi R; Miller A; Maron R; Weiner HL
    Nat Med; 2006 Jun; 12(6):627-35. PubMed ID: 16715091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunobiology of solid organ transplantation.
    Turvey SE; Wood KJ
    Int Surg; 1999; 84(4):279-90. PubMed ID: 10667806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies for the therapeutic induction of tolerance.
    Waldmann H; Qin S; Cobbold SP
    Immunol Ser; 1993; 59():85-99. PubMed ID: 8461402
    [No Abstract]   [Full Text] [Related]  

  • 13. Otelixizumab in the treatment of type 1 diabetes mellitus.
    Sprangers B; Van der Schueren B; Gillard P; Mathieu C
    Immunotherapy; 2011 Nov; 3(11):1303-16. PubMed ID: 22053883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of CD3 antibodies in transplantation and autoimmune diseases.
    Chatenoud L
    Transplant Proc; 1994 Dec; 26(6):3191-3. PubMed ID: 7998111
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody.
    Ishikawa H; Ochi H; Chen ML; Frenkel D; Maron R; Weiner HL
    Diabetes; 2007 Aug; 56(8):2103-9. PubMed ID: 17456848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Organ transplantation: epidemiological and immunological aspects; principles of treatment and surveillance; complications and prognosis; ethical and legal aspects].
    Lebranchu Y; Sirinelli A; Wolf P; Mornex JF
    Rev Prat; 2004 Dec; 54(20):2295-304; quiz 2304. PubMed ID: 15736544
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction of dominant tolerance using monoclonal antibodies.
    Agua-Doce A; Graça L
    Methods Mol Biol; 2007; 380():405-29. PubMed ID: 17876109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD25 mAb, anti-IL2 mAb, and IL2 block tolerance induction through anti-CD154 mAb and rapamycin in xenogeneic islet transplantation.
    Pan H; Lu HM; Hu WM; Tian BL; Liu XB; Zhang ZD; Mai G
    Transplant Proc; 2007 Dec; 39(10):3452-4. PubMed ID: 18089405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of antibody treatment on regulatory CD4(+)CD25(+) T cells.
    Yi H; Zhang J; Zhao Y
    Transpl Immunol; 2008 Apr; 19(1):37-44. PubMed ID: 18346636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs in autoimmune diseases.
    Herrmann DB; Bicker U
    Klin Wochenschr; 1990; 68 Suppl 21():15-25. PubMed ID: 2198387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.